search
Back to results

Redes II National Patient Navigator Intervention Study

Primary Purpose

Breast Cancer

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Patient Navigated Latinas
Non Navigated Latinas
Sponsored by
The University of Texas Health Science Center at San Antonio
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Breast Cancer focused on measuring Breast cancer, Patient Navigation, Health Disparities, Latinas, Breast Imaging Reporting and Data System, BI-RADS, underserved

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • English and Spanish speaking female Hispanics over 18 years of age who attend this clinic and who receive mammography screening results specified as BI-RADS 3, 4 or 5, will be offered participation in the study.
  • Although not actively recruited, pregnant women will not be excluded from the study sample

Exclusion Criteria:

-

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Active Comparator

    Arm Label

    Patient Navigated Latinas

    Non Navigated Latinas

    Arm Description

    Patient navigators provided culturally sensitive support and guidance to Latina women who presented radiologic abnormalities categorized as BI-RADS 3, 4 and 5. Patient Navigators also collected clinical information from the patients' medical charts.

    A convenience sampling approach was used to recruit non navigated Latinas. Eligibility criteria targeted self-identified Latinas at community-based health clinics, aged > 18 years with an abnormal breast screening mammogram resulting in BI-RADS 3, 4 or 5. Controls were chosen by determining eligibility consecutively backwards from the study start date.

    Outcomes

    Primary Outcome Measures

    T0-T1; Days from Index Screening to Diagnosis
    Number of days from date of index screening abnormality to definitive diagnosis and the proportion achieving timely diagnosis (within 30 days or 60 days of screening).
    T1-T2; Days from Diagnosis to Treatment Initiation
    Number of days from date of definitive diagnosis to initiation of treatment and the proportion achieving timely treatment (within 30 or 60 days of diagnosis)

    Secondary Outcome Measures

    # Barriers
    Relationship of # of reported barriers by navigated women and relationship of it to T0-T1 and T1-T2
    Patient Satisfaction
    Patient satisfaction with navigation provided as measured by Patient Satisfaction scale
    Mental Health Status
    Patient mental health status pre- and post-navigation

    Full Information

    First Posted
    October 15, 2014
    Last Updated
    October 20, 2014
    Sponsor
    The University of Texas Health Science Center at San Antonio
    Collaborators
    The Brooklyn Hospital Center, University of Miami Sylvester Comprehensive Cancer Center, The University of Texas Health Science Center, Houston, University of California, San Francisco, University of California, San Diego
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02269033
    Brief Title
    Redes II National Patient Navigator Intervention Study
    Official Title
    Redes en Acción: National Patient Navigator Intervention Study
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    October 2014
    Overall Recruitment Status
    Completed
    Study Start Date
    September 2008 (undefined)
    Primary Completion Date
    September 2010 (Actual)
    Study Completion Date
    September 2010 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    The University of Texas Health Science Center at San Antonio
    Collaborators
    The Brooklyn Hospital Center, University of Miami Sylvester Comprehensive Cancer Center, The University of Texas Health Science Center, Houston, University of California, San Francisco, University of California, San Diego

    4. Oversight

    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    The purpose of this study is to assess the efficacy of a "patient navigator" program that uses a trained community lay health worker to assist Hispanic patients in utilizing cancer care services. This study is a two part study. The first part of the study consists of a retrospective data collection procedure called "baseline clinical chart audit" of 50 Hispanic women over 18 years of age who have had a mammography abnormality classified as BI-RADS 3, 4 or 5. These data will be drawn from the study clinic's existing records and will serve as baseline data for subjects recruited during the course of the study. The second part of the study, the intervention group, involves the recruitment of 50 low-income, Hispanic women who receive abnormal breast cancer screening results (also classified as BI-RADS 3, 4 or 5) from screening services at local community health clinics. Participants will have significantly higher compliance rates and significantly shorter time lags and between an abnormal screening result, and confirmatory screening tests and commencement of treatment, compared to our baseline. The investigators expect at least a 12% increase in after-screening compliance rate and a 25% reduction in time lags in the treatment group, in relation to the pre-intervention baseline assessment.
    Detailed Description
    Breast cancer is the leading cause of cancer-related deaths in Latinas, chiefly because of later diagnosis. The time from screening to diagnosis is critical to optimizing cancer care, yet the efficacy of navigation in reducing it is insufficiently documented. Here the investigators evaluate a culturally sensitive patient navigation program to reduce the time to diagnosis and increase the proportions of women diagnosed within 30 days and 60 days. METHODS. The investigators analyzed 425 Latinas who had Breast Imaging Reporting and Data System (BI-RADS) radiologic abnormalities categorized as BI-RADS-3, BI-RADS-4, or BI-RADS-5 from July 2008 to January 2011. There were 217 women in the navigated group and 208 women in the control group. Women were navigated by locally trained navigators or were not navigated (data for this group were abstracted from charts). The Kaplan-Meier method, Cox proportional hazards regression, and logistic regression were used to determine differences between groups. RESULTS. The time to diagnosis was shorter in the navigated group (mean, 32.5 days vs 44.6 days in the control group; hazard ratio, 1.32; P ¼ .007). Stratified analysis revealed that navigation significantly shortened the time to diagnosis among women who had BI-RADS-3 radiologic abnormalities (mean, 21.3 days vs 63.0 days; hazard ratio, 2.42; P < .001) but not among those who had BI-RADS-4 or BI-RADS-5 radiologic abnormalities (mean, 37.6 days vs 36.9 days; hazard ratio, 0.98; P ¼ .989). Timely diagnosis occurred more frequently among navigated Latinas (within 30 days: 67.3% vs 57.7%; P ¼ .045; within 60 days: 86.2% vs 78.4%; P ¼ .023). This was driven by the BI-RADS-3 strata (within 30 days: 83.6% vs 50%; P < .001; within 60 days: 94.5% vs 67.2%; P < .001). A lack of missed appointments was associated with timely diagnosis. CONCLUSIONS. Patient-centered navigation to assist Latina women with abnormal screening mammograms appeared to reduced the time to diagnosis and increase rates of timely diagnosis overall. However, in stratified analyses, only navigated Latinas with an initial BI-RADS-3 screen benefited, probably because of a reduction in missed diagnostic appointments in this group.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Breast Cancer
    Keywords
    Breast cancer, Patient Navigation, Health Disparities, Latinas, Breast Imaging Reporting and Data System, BI-RADS, underserved

    7. Study Design

    Primary Purpose
    Supportive Care
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    480 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Patient Navigated Latinas
    Arm Type
    Experimental
    Arm Description
    Patient navigators provided culturally sensitive support and guidance to Latina women who presented radiologic abnormalities categorized as BI-RADS 3, 4 and 5. Patient Navigators also collected clinical information from the patients' medical charts.
    Arm Title
    Non Navigated Latinas
    Arm Type
    Active Comparator
    Arm Description
    A convenience sampling approach was used to recruit non navigated Latinas. Eligibility criteria targeted self-identified Latinas at community-based health clinics, aged > 18 years with an abnormal breast screening mammogram resulting in BI-RADS 3, 4 or 5. Controls were chosen by determining eligibility consecutively backwards from the study start date.
    Intervention Type
    Behavioral
    Intervention Name(s)
    Patient Navigated Latinas
    Intervention Description
    Patient navigators provided culturally sensitive support and guidance to Latina women who presented radiologic abnormalities categorized as BI-RADS 3, 4 and 5. Patient Navigators also collected clinical information from the patients' medical charts.
    Intervention Type
    Behavioral
    Intervention Name(s)
    Non Navigated Latinas
    Intervention Description
    A convenience sampling approach was used to recruit non navigated Latinas. Eligibility criteria targeted self-identified Latinas at community-based health clinics, aged > 18 years with an abnormal breast screening mammogram resulting in BI-RADS 3, 4 or 5. Controls were chosen by determining eligibility consecutively backwards from the study start date.
    Primary Outcome Measure Information:
    Title
    T0-T1; Days from Index Screening to Diagnosis
    Description
    Number of days from date of index screening abnormality to definitive diagnosis and the proportion achieving timely diagnosis (within 30 days or 60 days of screening).
    Time Frame
    30 days
    Title
    T1-T2; Days from Diagnosis to Treatment Initiation
    Description
    Number of days from date of definitive diagnosis to initiation of treatment and the proportion achieving timely treatment (within 30 or 60 days of diagnosis)
    Time Frame
    30 days
    Secondary Outcome Measure Information:
    Title
    # Barriers
    Description
    Relationship of # of reported barriers by navigated women and relationship of it to T0-T1 and T1-T2
    Time Frame
    365 days
    Title
    Patient Satisfaction
    Description
    Patient satisfaction with navigation provided as measured by Patient Satisfaction scale
    Time Frame
    365 days
    Title
    Mental Health Status
    Description
    Patient mental health status pre- and post-navigation
    Time Frame
    365 days

    10. Eligibility

    Sex
    Female
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: English and Spanish speaking female Hispanics over 18 years of age who attend this clinic and who receive mammography screening results specified as BI-RADS 3, 4 or 5, will be offered participation in the study. Although not actively recruited, pregnant women will not be excluded from the study sample Exclusion Criteria: -
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Amelie G Ramirez, DrPH
    Organizational Affiliation
    The University of Texas Health Science Center at San Antonio
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Learn more about this trial

    Redes II National Patient Navigator Intervention Study

    We'll reach out to this number within 24 hrs